Immunohistochemical localization of aspartoacylase in the rat central nervous system
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aspartoacylase (ASPA; EC 3.5.1.15) catalyzes deacetylation of N‐acetylaspartate (NAA) to generate free acetate in the central nervous system (CNS). Mutations in the gene coding ASPA cause Canavan disease (CD), an autosomal recessive neurodegenerative disease that results in death before 10 years of age. The pathogenesis of CD remains unclear. Our working hypothesis is that deficiency in the supply of the NAA‐derived acetate leads to inadequate lipid/myelin synthesis during development, resulting in CD. To explore the localization of ASPA in the CNS, we used double‐label immunohistochemistry for ASPA and several cell‐specific markers. A polyclonal antibody was generated in rabbit against mouse recombinant ASPA, which reacted with a single band (∼37 kD) on Western blots of rat brain homogenate. ASPA colocalized throughout the brain with CC1, a marker for oligodendrocytes, with 92–98% of CC1‐positive cells also reactive with the ASPA antibody. Many cells were labeled with ASPA antibodies in white matter, including cells in the corpus callosum and cerebellar white matter. Relatively fewer cells were labeled in gray matter, including cerebral cortex. No astrocytes were labeled for ASPA. Neurons were unstained in the forebrain, although small numbers of large reticular and motor neurons were faintly to moderately stained in the brainstem and spinal cord. Many ascending and descending neuronal fibers were moderately stained for ASPA in the medulla and spinal cord. Microglial‐like cells showed faint to moderate staining with the ASPA antibodies throughout the brain by the avidin/biotin‐peroxidase detection method, and colocalization studies with labeled lectins confirmed their identity as microglia. The predominant immunoreactivity in oligodendrocytes is consistent with the proposed role of ASPA in myelination, supporting the case for acetate supplementation as an immediate and inexpensive therapy for infants diagnosed with CD. J. Comp. Neurol. 472:318–329, 2004. Published 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413 · cited 1×
“…was tested by Western blotting against the cytosolic fraction of the rat brain homogenate (10% wt/vol) obtained by centrifugation (16,000g, 30 minutes) and the myelin fraction obtained by sucrose density gradient centrifugation according to the procedure of Norton and Poduslo (1973).”
MethodDevelopmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination
Kirmani, B. F., Jacobowitz, D. M., & Namboodiri, M. A. A. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00592-8 · Cited by 71
Self-citation
Cited by
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.003 · Cited by 1,405
Self-citationVagnozzi, R., Signoretti, S., Cristofori, L., Alessandrini, F., Floris, R., Isgro, E., Ria, A., Marziale, S., Zoccatelli, G., Tavazzi, B., et al. (2010) · Brain · doi:10.1093/brain/awq200 · Cited by 392
Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
Chrast, R., Saher, G., Nave, K.-A., & Verheijen, M. H. G. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009761 · Cited by 314
Long-term follow-up after gene therapy for canavan disease
Leone, P., Shera, D., McPhee, S. W. J., Francis, J. S., Kolodny, E. H., Bilaniuk, L. T., Wang, D.-J., Assadi, M., Goldfarb, O., Goldman, H. W., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003454 · Cited by 307
Vostrikov, V. M., Uranova, N. A., & Orlovskaya, D. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.014 · Cited by 233
“NAA synthesized and stored primarily in neurons, although it is hydrolyzed by the hydrolytic enzyme aspartoacylase (ASPA) that is localized in oligodendrocytes (Madhavarao et al., 2004).”
BackgroundTraka, M., Wollmann, R. L., Cerda, S. R., Dugas, J., Barres, B. A., & Popko, B. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1490-08.2008 · Cited by 82
“ASPA is highly expressed in mature oligodendrocytes (Baslow et al., 1999; Madhavarao et al., 2004; Dugas et al., 2006), where it catalyzes the hydrolysis of the most abundant amino acid in the brain, N-acetylaspartate (NAA) (Moffett et al.”
BackgroundMethodAra, J., See, J., Mamontov, P., Hahn, A., Bannerman, P., Pleasure, D., & Grinspan, J. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21462 · Cited by 79
“Occasionally there were GFAP-positive astrocytes also labeled with BMP4 as well as a few oligodendrocytes, which were labeled with antibody to aspartoacylase (ASPA; Madhavarao et al., 2004; Namboodiri et al., 2006; Fig.”
Oligodendroglial Energy Metabolism and (re)Myelination
Tepavčević, V. (2021) · Life · doi:10.3390/life11030238 · Cited by 57
“NAA is produced by neurons, and aspartoacetylase (ASPA), the enzyme that catabolyzes NAA into L-aspartate and acetate is expressed by oligodendrocytes[78].”
BackgroundKlugmann, M., Leichtlein, C. B., Symes, C. W., Serikawa, T., Young, D., & During, M. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.006 · Cited by 55
“NAA is synthesized in neuronal mitochondria and microsomes [10] and degraded by ASPA, a cytosolic enzyme almost exclusively expressed in oligodendrocytes [11,12].”
BackgroundResultMarian, O. C., Teo, J. D., Lee, J. Y., Song, H., Kwok, J. B., Landin-Romero, R., Halliday, G., & Don, A. S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01544-7 · Cited by 50
Francis, J. S., Wojtas, I., Markov, V., Gray, S. J., McCown, T. J., Samulski, R. J., Bilaniuk, L. T., Wang, D.-J., De Vivo, D. C., Janson, C. G., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.10.001 · Cited by 49
“…is an autosomal recessive leukodystrophy caused by deficiency in aspartoacylase (ASPA) (Hagenfeldt et al., 1987), an oligodenroglial enzyme (Baslow et al., 1999) (Madhavarao et al., 2004) (Dugas et al., 2006) (Francis et al., 2011) (Zhang et al., 2014) that catabolizes N-acetyl-aspartate (NAA).”
BackgroundFrancis, J. S., Markov, V., Wojtas, I. D., Gray, S., McCown, T., Samulski, R. J., Figueroa, M., & Leone, P. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.01.009 · Cited by 41
Aspartoacylase supports oxidative energy metabolism during myelination
Francis, J. S., Strande, L., Markov, V., & Leone, P. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.66 · Cited by 41
“Although ASPA has been reported in nonoligodendroglial cells (Madhavarao et al, 2004), in our experience, the vast majority of ASPA-positive cells in the rodent brain colocalize with the APC antigen (Francis et al, 2011), and the transcriptional and activity profile of the Figure 8 Partial rescue…”
BackgroundPoggi, G., Albiez, J., & Pryce, C. R. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100451 · Cited by 31
Krauspe, B. M., Dreher, W., Beyer, C., Baumgartner, W., Denecke, B., Janssen, K., Langhans, C.-D., Clarner, T., & Kipp, M. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0412-6 · Cited by 22
“In contrast, ASPA appears not to be expressed by astrocytes (Madhavarao et al., 2004).”
BackgroundInfluentialKawai, K., Itoh, T., Itoh, A., Horiuchi, M., Wakayama, K., Bannerman, P., Garbern, J. Y., Pleasure, D., & Lindsten, T. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06988.x · Cited by 21
“15) (Madhavarao et al., 2004) and quantified in 6-lm cross-sections of the optic nerve and the dorsal column of the spinal cord at the first thoracic spinal segment.”
BackgroundInfluentialSaito, L. B., Fernandes, J. P., Smith, M. J., Doan, M. A. L., Branton, W. G., Schmitt, L. M., Wuest, M., Monaco, M. C., Major, E. O., Wuest, F., et al. (2021) · Glia · doi:10.1002/glia.23896 · Cited by 18
“It is plausible that the reduced neuroinflammation associated with VX-765 treatment might enhance function of preserved oligodendrocytes, given our findings of protected myelin (MBP immunoreactivity) despite the lack of oligodendrocyte (ASPA immunoreactivity) rescue (Figure 5).”
BackgroundInfluentialEndogenous aspartoacylase expression is responsive to glutamatergic activity in vitro and in vivo
Francis, J. S., Strande, L., Pu, A., & Leone, P. (2011) · Glia · doi:10.1002/glia.21187 · Cited by 12
“Although ASPA immunoreactivity is most concentrated within subcortical white matter tracts, positive cells are also found within relatively neuron-rich areas of the brain (Madhavarao et al., 2004).”
Background
Metadata
- Authors
- Madhavarao, C. N., Moffett, J. R., Moore, R. A., Viola, R. E., Namboodiri, M. A. A., & Jacobowitz, D. M.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2004-03-26
- Volume
- 472
- Issue
- 3
- Pages
- 318-329
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2084141308
- Cited by
- 146
- References
- 2
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.